Atea Pharmaceuticals, Inc.

AVIRNASDAQHealthcare● Active

$4.32

+$0.07(+1.65%)

Market Cap$345717068

P/E Ratio—

52W High$6.45

52W Low$2.78

Avg Volume434K

Open$4.25

Beta0.32

Net Income Financials Revenue

Atea Pharmaceuticals, Inc. (AVIR) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

AVIR · net income · updated Jun 8, 2026

Core profitability metrics

AVIR · net income · margin · TTM · CAGR

Net income was −$158.3M for FY2025 (fiscal year ending 2025-12-31), up 6.0% year-over-year. Net profit margin was —. Based on available data, Atea Pharmaceuticals, Inc. has been profitable since at least 2021.

FY2025 Net Income−$158.3M▲ +6.0% YoY

Trailing 12M (TTM)−$169.5Mtrailing 4 quarters sum

Net Profit Margin——

YoY Change+6.0%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 8, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2021

▸ FMP /income-statement · Annual · AVIR net income history · AVIR profit margin

Annual net income data

AVIR · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025Loss−$158.3M▲ +6.0%—$0

FY2024Loss−$168.4M▼ 23.9%—$0

FY2023Loss−$136.0M▼ 17.3%—$0

FY2022Loss−$115.9M▼ 195.6%—$0

FY2021★ First Profit$121.2M▲ +1207.1%34.5%$351.4M

Net income vs peers (Healthcare)

AVIR vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

Atea Pharmaceuticals, Inc.YOU

AVIR

−$158.3M+6.0%—

Loss

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Atea Pharmaceuticals, Inc. (AVIR) reported net income of −$158.3M for FY2025 (fiscal year ending 2025-12-31), up 6.0% year-over-year. The net profit margin was — — meaning the company kept $— of every dollar of revenue as profit.

Based on available data, Atea Pharmaceuticals, Inc. has been profitable since at least 2021. Net income reached a peak of $121.2M in FY2021. Data available for 8 fiscal years.

Atea Pharmaceuticals, Inc.'s net profit margin was — for FY2025, based on the latest annual results.

Investors sometimes search for "Atea Pharmaceuticals, Inc. net worth" — the company's market capitalization is a separate figure from AVIR net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

AVIR net income · 4 questions

Atea Pharmaceuticals, Inc. is not currently profitable on an annual basis. The company reported a net loss of $158.3M for FY2025.

is AVIR profitabledoes AVIR make a profitAVIR profitabilityAVIR profitable company

▸ Source: FMP /income-statement · GAAP · Atea Pharmaceuticals, Inc. · Atea Pharmaceuticals, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026